A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies
Clinical trial NCT05957367 · RECRUITING
Trial details
- NCT number
- NCT05957367
- Sponsor
- Deciphera Pharmaceuticals, LLC
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-28
- Primary completion
- 2027-03-01
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.